O75469 (NR1I2_HUMAN) Homo sapiens (Human)

Nuclear receptor subfamily 1 group I member 2 UniProtKBInterProSTRINGInteractive Modelling

434 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7)

Available Structures

67 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of the SR12813-bound PXR/RXRalpha LBD Heterotetramer Complex Heteromer
P19793; Q15788;
139-434
100.0SRL;
Crystal Structure of PXR LBD Complexed with SJB7 Heteromer
Q15788;
139-432
100.04WH;
Crystal Structure of the apo-PXR/RXRalpha LBD Heterotetramer Complex Heteromer
P19793;
141-434
100.0MG;
Crystal Structure of the human PXR-LBD in complex with an SRC-1 coactivator peptide and SR12813 Heteromer
Q15788;
142-433
100.0SRL;
Structure of pregnane X receptor in complex with a Sphingosine 1- Phosphate Receptor 1 Antagonist Heteromer
Q15788;
141-432
100.0D7E;
Crystal Structure of the Human Pregnane X Receptor LBD in complex with an SRC-1 coactivator peptide… Heteromer
P70365;
142-433
99.64444;
Crystal structure of pregnane X receptor ligand binding domain complexed with JQ1 Heteromer
Q15788;
142-432
100.0JQ1;
STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND WITH ADNECTIN-1 AND COMPOUND-1 Heteromer
142-431
100.040U;
STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN with ADNECTIN-1 Heteromer
143-429
100.0
CRYSTAL STRUCTURE OF PXR IN COMPLEX WITH XPC-7455homo-2-mer138-434
100.0KUB;
STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TETHERED WITH SRC CO-ACTIVATOR P…homo-2-mer141-434
100.0L7D;
Crystal structure of the hPXR-LBD in complex with the synthetic estrogen 17alpha-ethinylestradiolhomo-2-mer142-434
100.03WF;MPD;
Crystal structure of the human PXR ligand-binding domain in complex with sclareolhomo-2-mer142-434
100.0UK6;GOL;
The structure of human pregnane X receptor in complex with an SRC-1 coactivator peptide and a limon…homo-2-mer142-434
100.0G3L;
Crystal structure of the L428V mutant of pregnane X receptor ligand binding domain in complex with …homo-2-mer142-434
99.63WU6;DMS;
Crystal structure of the apo form of pregnane X receptor ligand binding domainhomo-2-mer142-434
100.0
Crystal structure of the hPXR-LBD in complex with the synthetic estrogen 17alpha-ethinylestradiol a…homo-2-mer142-434
100.03WF;3WG;MPD;IPA;
Tethered PXR-LBD/SRC-1p bound to Garcinoic Acidhomo-2-mer142-434
100.0NQD;DMS;
Crystal structure of pregnane X receptor ligand binding domain in complex with SJPYT-310homo-2-mer142-434
100.0WSO;DMS;
Crystal structure of pregnane X receptor ligand binding domain complexed with T0901317 analog T0-C6homo-2-mer142-434
100.0WQB;
Crystal structure of pregnane X receptor ligand binding domain in complex with SJPYT-331homo-2-mer142-434
100.0WU6;DMS;
STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TETHERED WITH SRC co-activator p…homo-2-mer142-434
100.0XGH;
Crystal structure of the hPXR-LBD obtained in presence of the pesticide trans-nonachlorhomo-2-mer142-434
100.0IPA;MPD;
Crystal structure of pregnane X receptor ligand binding domain in complex with SJPYT-328homo-2-mer142-434
100.0WU2;
Crystal structure of pregnane X receptor ligand binding domain in complex with SJPYT-312homo-2-mer142-434
100.0WSX;DMS;
Crystal Structure of the Pregnane X Receptor bound to Colupulonehomo-2-mer142-434
100.0CDZ;
Crystal structure of the L428V mutant of pregnane X receptor ligand binding domain in apo formhomo-2-mer142-434
99.63GOL;
Crystal structure of pregnane X receptor ligand binding domain in complex with SJPYT-326homo-2-mer142-434
100.0DMS;WT1;
Crystal structure of pregnane X receptor ligand binding domain in complex with SJPYT-278homo-2-mer142-434
100.0WSX;YGO;
CRYSTAL STRUCTURE OF PXR IN COMPLEX WITH COMPOUND 7homo-2-mer142-426
100.0HCJ;
Crystal structure of the hPXR-LBD in complex with oxadiazonmonomer140-434
100.0GOL;S6Z;IPA;
Crystal structure of the human PXR ligand-binding domain in complex with liranaftatemonomer140-434
100.0ULC;
Crystal structure of hPXR in complex with dabrafenibmonomer140-434
100.0P06;IPA;
Crystal structure of the hPXR-LBD in complex with pretilachlormonomer140-434
100.0S6T;IPA;
Crystal structure of the hPXR-LBD in complex with estradiol and heptachlor endo-epoxidemonomer140-434
100.0EST;S65;MPD;
Crystal structure of the hPXR-LBD in complex with alpha-zearalanolmonomer141-434
100.0IPA;MPD;27J;
PXR IN COMPLEX WITH THROMBIN INHIBITOR COMPOUND 17monomer142-434
100.0GOL;MPD;PO4;
Crystal structure of the hPXR-LBD in complex with estradiol and endosulfanmonomer142-434
100.0EST;MPD;S68;GOL;
Tethered PXR-LBD/SRC-1p apoproteinmonomer142-434
100.0
human PXR LBD bound to GSK002monomer142-434
100.05YU;
Crystal structure of the hPXR-LBD in complex with ferutininemonomer142-434
100.027H;GOL;IPA;
Tethered PXR-LBD/SRC-1p complexed with SR-12813monomer142-434
100.0SRL;
Crystal Structure of the Human Pregane X Receptor Ligand Binding Domain in Complex with Hyperforin,…monomer142-434
100.0HYF;
Crystal structure of the hPXR-LBD in complex with estradiol and cis-chlordanemonomer142-434
100.0EST;MPD;S6E;S6H;IPA;
Crystal structure of the hPXR-LBD in apo form (P43212 SG)monomer142-434
100.0EDO;
human PXR LBD bound to GSK001monomer142-434
100.0P06;
Crystal structure of pregnane X receptor ligand binding domain complexed with T0901317 analog SJPYT…monomer142-434
100.0X1D;
PXR in complex with P2X4 inhibitor compound 25monomer142-434
100.0GOL;DMS;
Crystal structure of pregnane X receptor ligand binding domain complexed with rifamycin Smonomer142-434
100.0VA0;
Crystal structure of the hPXR-LBD in complex with cis-chlordanemonomer142-434
100.0S6H;IPA;GOL;
human PXR LBD bound to compound 2monomer142-434
100.007F;
Crystal structure of the hPXR-LBD in complex with clotrimazolemonomer142-434
100.0CL6;
STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN BOUND TETHERED WITH SRC co-activator p…monomer142-434
100.0QCG;
Crystal structure of pregnane X receptor ligand binding domain complexed with T0901317 analog T0-BPmonomer142-434
100.0Y5B;
Crystal structure of the hPXR-LBD in complex with estradiol and clotrimazolemonomer142-434
100.0CL6;EST;
Crystal structure of the hPXR-LBD in complex with endosulfanmonomer142-434
100.0MPD;S68;GOL;
Crystal structure of pregnane X receptor ligand binding domain complexed with AP1867monomer142-434
100.0AP1;
Crystal structure of the hPXR-LBD in complex with fipronilmonomer142-434
100.0S6W;IPA;
Crystal structure of the hPXR-LBD in complex with tributyltinmonomer142-434
100.0TBY;
Crystal structure of the human PXR ligand-binding domain in complex with 2,2'-dichloro bisphenol Amonomer142-434
100.0UAI;
human PXR LBD bound to GSK003monomer142-433
100.05YX;
STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN WITH COMPOUND-1monomer142-431
100.0GOL;40U;
Crystal Structure of Apo Human Pregnane X Receptor Ligand Binding Domainmonomer142-431
100.0
Crystal Structure of Human Pregnane X Receptor Ligand Binding Domain Bound to SR12813monomer142-431
100.0SRL;
Crystal Structure Of the Human PXR-LBD In Complex With N-{(2R)-1-[(4S)-4-(4-chlorophenyl)-4-hydroxy…monomer142-431
100.02Q4;GOL;
Activation of the Human Nuclear Xenobiotic Receptor PXR by the Reverse Transcriptase-Targeted Anti-…monomer142-431
100.0PNU;
Structural Disorder in the Complex of Human PXR and the Macrolide Antibiotic Rifampicinmonomer143-431
100.0RFP;

11 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7yfk.1.Ahomo-2-mer0.81142-432
G3L;100.00
7wnh.4.Amonomer0.5641-430
ZN;25.83
4iqr.2.Bmonomer0.5639-430
ZN;26.10
3dzy.1.Bmonomer0.5538-430
ZN;26.65
7wnh.2.Amonomer0.5540-429
ZN;25.83
4iqr.2.Amonomer0.5439-430
ZN;26.10
3dzu.1.Amonomer0.5438-429
ZN;24.54
5uan.1.Amonomer0.5339-431
ZN;23.71
4nqa.2.Amonomer0.5334-432
ZN;23.71
7prv.1.Amonomer0.5037-432
ZN;20.06
7prw.1.Bmonomer0.5038-432
ZN;20.06

68 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28eqz.1.Ahomo-2-mer0.8487-377
WQB;100.00
Isoform 27wnh.4.Amonomer0.561-375
25.48
Isoform 27wnh.2.Amonomer0.551-374
ZN;25.48
Isoform 23dzy.1.Bmonomer0.541-375
25.07
Isoform 24iqr.2.Bmonomer0.541-376
ZN;24.08
Isoform 24iqr.2.Amonomer0.531-376
ZN;24.08
Isoform 23dzy.1.Amonomer0.531-374
ZN;23.13
Isoform 24nqa.2.Amonomer0.531-377
22.80
Isoform 36nx1.2.Ahomo-2-mer0.82164-455
L7D;100.00
Isoform 37wnh.4.Amonomer0.5664-453
ZN;26.20
Isoform 37wnh.2.Amonomer0.5663-452
ZN;26.20
Isoform 33dzy.1.Bmonomer0.5661-454
ZN;26.65
Isoform 34iqr.2.Bmonomer0.5562-454
ZN;25.71
Isoform 34iqr.2.Amonomer0.5462-454
ZN;25.71
Isoform 33dzy.1.Amonomer0.5361-452
ZN;24.85
Isoform 35uan.1.Amonomer0.5362-454
ZN;23.78
Isoform 34nqa.2.Amonomer0.5358-455
ZN;23.78
Isoform 37prw.1.Amonomer0.5059-455
ZN;19.88
Isoform 44nqa.1.Bmonomer0.6433-393
31.61
Isoform 44nqa.2.Bmonomer0.6333-394
31.61
Isoform 45uan.1.Bmonomer0.6340-393
ZN;30.54
Isoform 47wnh.4.Amonomer0.6041-394
ZN;25.75
Isoform 47wnh.2.Amonomer0.6040-392
ZN;25.75
Isoform 44iqr.2.Bmonomer0.5939-394
ZN;24.76
Isoform 44iqr.2.Amonomer0.5939-394
ZN;24.76
Isoform 43e00.1.Bmonomer0.5837-394
ZN;26.78
Isoform 44nqa.1.Amonomer0.5834-393
ZN;23.33
Isoform 43dzy.1.Amonomer0.5838-392
ZN;24.54
Isoform 45uan.1.Amonomer0.5739-394
ZN;23.33
Isoform 47prw.1.Bmonomer0.5638-395
ZN;19.23
Isoform 47prw.1.Amonomer0.5535-395
ZN;19.23
Isoform 47kw7.1.Fmonomer0.55149-395
19.88
Isoform 44nqa.2.Amonomer0.5131-391
ZN;30.03
Isoform 56hj2.1.Amonomer0.8485-342
P06;100.00
Isoform 54nqa.1.Bmonomer0.631-338
29.54
Isoform 54nqa.2.Bmonomer0.631-339
29.54
Isoform 55uan.1.Bmonomer0.621-338
29.71
Isoform 57wnh.4.Amonomer0.601-338
24.84
Isoform 57wnh.2.Amonomer0.601-337
ZN;24.84
Isoform 54iqr.2.Bmonomer0.581-339
ZN;23.08
Isoform 54nqa.1.Amonomer0.581-338
ZN;22.48
Isoform 53e00.1.Bmonomer0.581-339
25.45
Isoform 57prw.1.Bmonomer0.561-340
ZN;17.72
Isoform 57prw.1.Amonomer0.551-340
ZN;17.72
Isoform 64nqa.1.Bmonomer0.6457-416
32.28
Isoform 64nqa.2.Bmonomer0.6457-417
32.28
Isoform 67wnh.4.Amonomer0.6064-416
ZN;25.90
Isoform 67wnh.2.Amonomer0.5963-415
ZN;25.90
Isoform 64iqr.2.Bmonomer0.5962-417
ZN;24.45
Isoform 64iqr.2.Amonomer0.5862-417
ZN;24.45
Isoform 64nqa.1.Amonomer0.5858-416
ZN;23.48
Isoform 63dzy.1.Amonomer0.5861-415
ZN;24.85
Isoform 63dzy.1.Bmonomer0.5861-417
ZN;26.86
Isoform 65uan.1.Amonomer0.5762-417
ZN;23.48
Isoform 67prw.1.Amonomer0.5559-418
ZN;19.05
Isoform 67prw.1.Bmonomer0.5561-418
ZN;19.05
Isoform 64nqa.2.Amonomer0.5054-414
ZN;30.03
Isoform 76nx1.2.Ahomo-2-mer0.82180-471
L7D;100.00
Isoform 77wnh.4.Amonomer0.5780-469
ZN;26.20
Isoform 73dzy.1.Bmonomer0.5677-470
ZN;26.65
Isoform 77wnh.2.Amonomer0.5679-468
ZN;26.20
Isoform 74iqr.2.Bmonomer0.5578-470
ZN;25.47
Isoform 74nqa.2.Amonomer0.5473-471
ZN;23.71
Isoform 74iqr.2.Amonomer0.5478-470
ZN;25.47
Isoform 73dzy.1.Amonomer0.5477-468
ZN;24.54
Isoform 75uan.1.Amonomer0.5378-470
ZN;23.71
Isoform 77prw.1.Bmonomer0.5177-471
ZN;19.88
Isoform 77prw.1.Amonomer0.5075-471
ZN;19.88